Global Medical REIT Inc (NASDAQ:GMRE) – Investment analysts at DA Davidson cut their FY2017 EPS estimates for Global Medical REIT in a report issued on Thursday. DA Davidson analyst B. Oxford now forecasts that the company will post earnings per share of $0.31 for the year, down from their prior estimate of $0.32. DA Davidson currently has a “Neutral” rating and a $10.00 target price on the stock. DA Davidson also issued estimates for Global Medical REIT’s Q1 2018 earnings at $0.15 EPS and FY2018 earnings at $0.71 EPS.

Global Medical REIT (NASDAQ:GMRE) last issued its quarterly earnings results on Thursday, August 10th. The company reported ($0.04) EPS for the quarter, missing the Zacks’ consensus estimate of $0.13 by ($0.17). The business had revenue of $7.42 million for the quarter, compared to analysts’ expectations of $6.16 million. Global Medical REIT had a negative net margin of 8.39% and a negative return on equity of 1.53%.

ILLEGAL ACTIVITY WARNING: “Global Medical REIT Inc Expected to Post FY2017 Earnings of $0.31 Per Share (GMRE)” was published by American Banking News and is owned by of American Banking News. If you are viewing this piece on another website, it was copied illegally and republished in violation of United States and international trademark & copyright law. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/09/15/global-medical-reit-inc-expected-to-post-fy2017-earnings-of-0-31-per-share-gmre.html.

Several other equities analysts have also recently issued reports on the company. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $12.00 price objective on shares of Global Medical REIT in a research report on Friday, September 1st. Zacks Investment Research cut Global Medical REIT from a “buy” rating to a “hold” rating in a research report on Tuesday, August 15th. TheStreet raised Global Medical REIT from a “d” rating to a “c-” rating in a research report on Monday, July 10th. Finally, FBR & Co reaffirmed an “outperform” rating and issued a $10.00 price objective on shares of Global Medical REIT in a research report on Tuesday, July 11th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $10.50.

Shares of Global Medical REIT (NASDAQ GMRE) opened at 9.37 on Friday. The company’s 50 day moving average price is $9.34 and its 200-day moving average price is $8.86. Global Medical REIT has a 12 month low of $6.73 and a 12 month high of $10.64.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 9th. Investors of record on Tuesday, September 26th will be given a $0.20 dividend. The ex-dividend date of this dividend is Monday, September 25th. This represents a $0.80 annualized dividend and a yield of 8.54%.

In other Global Medical REIT news, Chairman Jeffrey Busch acquired 11,100 shares of the stock in a transaction that occurred on Friday, June 30th. The shares were acquired at an average cost of $9.00 per share, with a total value of $99,900.00. Following the transaction, the chairman now owns 20,110 shares of the company’s stock, valued at approximately $180,990. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

A number of institutional investors and hedge funds have recently made changes to their positions in GMRE. UBS Group AG raised its stake in Global Medical REIT by 14.2% during the 1st quarter. UBS Group AG now owns 11,847 shares of the company’s stock valued at $108,000 after buying an additional 1,477 shares during the last quarter. Spirit of America Management Corp NY raised its stake in Global Medical REIT by 50.0% during the 2nd quarter. Spirit of America Management Corp NY now owns 15,000 shares of the company’s stock valued at $134,000 after buying an additional 5,000 shares during the last quarter. Citadel Advisors LLC purchased a new stake in Global Medical REIT during the 1st quarter valued at $137,000. Wedbush Securities Inc. raised its stake in Global Medical REIT by 5.8% during the 2nd quarter. Wedbush Securities Inc. now owns 15,334 shares of the company’s stock valued at $137,000 after buying an additional 834 shares during the last quarter. Finally, Rhumbline Advisers raised its stake in Global Medical REIT by 47.6% during the 2nd quarter. Rhumbline Advisers now owns 17,699 shares of the company’s stock valued at $158,000 after buying an additional 5,710 shares during the last quarter.

Global Medical REIT Company Profile

Global Medical REIT Inc focuses on operating as a real estate investment trust. The Company is engaged primarily in the acquisition and leasing of licensed purpose-built healthcare facilities in certain markets with various clinical operators. The Company seeks to invest in these purpose-built, specialized facilities, such as surgery centers, specialty hospitals and outpatient treatment centers.

Earnings History and Estimates for Global Medical REIT (NASDAQ:GMRE)

Receive News & Ratings for Global Medical REIT Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT Inc and related companies with MarketBeat.com's FREE daily email newsletter.